C&R Research씨엔알리서치
359090 · KOSDAQ · ₩359090 · 씨엔알리서치
₩2,205▲ ₩30 (1.38%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩65B | ₩60B | ₩55B | ₩48B | ₩43B |
| Gross profit | ₩65B | ₩60B | ₩55B | ₩48B | ₩43B |
| Operating income | ₩1.4B | ₩3.6B | ₩6.2B | ₩4.7B | ₩5.8B |
| Net income | ₩1B | ₩3.4B | ₩5.6B | ₩3.9B | −₩3.3B |
| Net income to shareholders | ₩2.6B | ₩3.8B | ₩5.6B | ₩3.9B | −₩3.3B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩85B | ₩86B | ₩78B | ₩71B | ₩71B |
| Current assets | ₩41B | ₩44B | ₩37B | ₩29B | ₩36B |
| Cash and equivalents | ₩8.8B | ₩12B | ₩7.3B | ₩6.5B | ₩19B |
| Total liabilities | ₩37B | ₩39B | ₩35B | ₩34B | ₩41B |
| Current liabilities | ₩34B | ₩35B | ₩32B | ₩31B | ₩37B |
| Borrowings | ₩6.6B | ₩4.7B | ₩6.1B | ₩7.4B | ₩14B |
| Total equity | ₩48B | ₩47B | ₩42B | ₩36B | ₩30B |
| Shareholders' equity | ₩49B | ₩47B | ₩42B | ₩36B | ₩30B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩3.1B | ₩2.8B | ₩3.5B | ₩2.5B | ₩2.2B |
| Free cash flow | −₩3.1B | ₩2.8B | ₩3.5B | ₩2.5B | ₩2.2B |
| Dividends paid | −₩567M | — | — | — | — |
Consolidated where available. Amounts in won.
Also known as: C&R Research / 씨엔알리서치 / 359090 / KRX:359090
Source: KRX statistical information